CPIX (STOCKS)
Cumberland Pharmaceuticals Inc
$3.870000
+0.010000 (+0.26%)
Prev close: $3.860000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- A. J. Kazimi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57.88M
- Employees
- 91
- P/E (TTM)
- -16.56
- P/B (TTM)
- 2.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.06 | $0.00 | +0.0000 | +0.00% |
|
Jun 2025 (Q2)
|
$0.02 | $0.00 | +0.0000 | +0.00% |
|
Mar 2025 (Q1)
|
$0.16 | $0.00 | +0.0000 | +0.00% |
|
Dec 2024 (Q4)
|
$-0.02 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $41.28M |
| Benefits Costs and Expenses | $44.60M |
| Cost Of Revenue | $6.40M |
| Costs And Expenses | $44.60M |
| Gross Profit | $34.88M |
| Operating Expenses | $40.12M |
| Research and Development | $5.31M |
| Other Operating Expenses | $32.83M |
| Operating Income/Loss | -$3.26M |
| Income/Loss From Continuing Operations After Tax | -$3.34M |
| Income/Loss From Continuing Operations Before Tax | -$3.32M |
| Income Tax Expense/Benefit | -$39.99K |
| Interest Expense, Operating | $606.31K |
| Net Income/Loss | -$3.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$9.46K |
| Net Income/Loss Attributable To Parent | -$3.33M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.24 |
| Diluted Earnings Per Share | -$0.24 |
| Basic Average Shares | 14,924,720 |
| Diluted Average Shares | 14,924,720 |
| Assets | $65.90M |
| Current Assets | $29.94M |
| Inventory | $2.93M |
| Other Current Assets | $27.00M |
| Noncurrent Assets | $35.96M |
| Fixed Assets | $293.38K |
| Other Non-current Assets | $35.67M |
| Liabilities | $40.10M |
| Current Liabilities | $24.31M |
| Accounts Payable | $13.83M |
| Other Current Liabilities | $10.48M |
| Noncurrent Liabilities | $15.79M |
| Equity | $25.80M |
| Equity Attributable To Noncontrolling Interest | -$319.15K |
| Equity Attributable To Parent | $26.12M |
| Liabilities And Equity | $65.90M |
| Net Cash Flow From Operating Activities | $6.83M |
| Net Cash Flow From Operating Activities, Continuing | $6.83M |
| Net Cash Flow From Investing Activities | -$1.66M |
| Net Cash Flow From Investing Activities, Continuing | -$1.66M |
| Net Cash Flow From Financing Activities | -$7.44M |
| Net Cash Flow From Financing Activities, Continuing | -$7.44M |
| Net Cash Flow | -$2.27M |
| Net Cash Flow, Continuing | -$2.27M |
| Comprehensive Income/Loss | -$3.34M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.34M |
| Other Comprehensive Income/Loss | $0.00 |